U.S. Gas Utilities Stock News

NasdaqGS:DYN
NasdaqGS:DYNBiotechs

Dyne Therapeutics (DYN) Could Be 38% Undervalued As FDA Milestones Lift Pipeline Hopes

Dyne Therapeutics (DYN) has been in focus after back to back U.S. FDA milestones, including clearance to begin a Phase 1 trial for DYNE-302 and Priority Review for Duchenne candidate DYNE-251. See our latest analysis for Dyne Therapeutics. Recent regulatory milestones appear to be feeding into Dyne Therapeutics' share price momentum, with the stock at US$25.18 after a 15.56% 30 day share price return and a 150.55% 1 year total shareholder return, even as recent losses and the July follow on...
NYSE:STVN
NYSE:STVNLife Sciences

Stevanato Group (STVN) Could Be 19% Undervalued As Alina Pen Approvals Expand In Europe

Stevanato Group (STVN) stock is in focus after the company reported that liraglutide combination products using its Alina 30 and Alina 50 pen injectors received marketing authorizations in multiple European countries. See our latest analysis for Stevanato Group. The Alina approvals come as Stevanato Group’s share price shows mixed momentum, with a 30 day share price return of 8.23% and a 90 day share price return of 12.08%. However, the year to date share price return is down 3.55% and the 1...
NYSE:RITM
NYSE:RITMMortgage REITs

Is Rithm Capital (RITM) Undervalued As Strong Quarterly Earnings Lift Its Outlook?

What Rithm Capital’s Latest Quarter Tells Investors Rithm Capital (RITM) is back in focus after reporting second quarter 2026 results, with sales of US$236.69 million and net income of US$56.29 million. These figures underline stronger earnings available for distribution. See our latest analysis for Rithm Capital. Rithm Capital’s 1 day share price return of 0.10% and 7 day share price return of 8.33% sit against a year to date share price decline of 10.02% and a 5 year total shareholder...
NasdaqGS:TARS
NasdaqGS:TARSPharmaceuticals

The Bull Case For Tarsus Pharmaceuticals (TARS) Could Change Following Sharp EPS Estimate Cuts Amid Rising Sales

Tarsus Pharmaceuticals recently faced significantly lowered consensus earnings-per-share estimates and a low analyst ranking ahead of its June 2026 quarterly results, even as revenue was projected to increase year over year. This combination of weaker profit expectations and growing sales highlights a tension between top-line momentum and concerns about the company’s near-term earnings profile. Now we’ll examine how this sharp downward revision in earnings expectations may affect Tarsus...
NYSE:PFS
NYSE:PFSBanks

Provident Financial Services (PFS) Earnings Strength Keeps Valuation In Focus

Provident Financial Services (PFS) is back in focus after reporting record quarterly revenue and a 17% year over year increase in earnings per share, supported by strong commercial loan production and a sizable loan pipeline. See our latest analysis for Provident Financial Services. Provident Financial Services shares recently eased 0.72% on the day to $24.68, while the 90 day share price return of 10.28% and 1 year total shareholder return of 43.53% indicate momentum that has been building...
NYSE:YELP
NYSE:YELPInteractive Media and Services

Is Yelp’s (YELP) AI Restaurant Push Quietly Rewriting Its Core Competitive Moat?

In July 2026, Yelp Inc. reported that its AI-powered Yelp Host for restaurants has now handled over 1 million calls since launching in October 2025, added OpenTable integration across the US and Canada, and expanded into takeout ordering via direct POS connections with systems like Toast, Square, and Clover. This marks Yelp’s push beyond reservations into end-to-end, AI-driven restaurant operations, potentially deepening its role in automating front-of-house and takeout workflows for both...
NYSE:SRE
NYSE:SREIntegrated Utilities

Sempra (SRE) Stock Looks Above Fair Value Despite Fair Earnings Pricing

Sempra stock has delivered a 56.5% total return over the past five years, yet its current checks suggest the shares do not stand out as a clear bargain today. Recent headlines around wildfire liability debates and major LNG project timing give investors fresh reasons to reassess what they are paying for the company’s future cash flows. A 56.5% gain over five years highlights that Sempra has already rewarded long term holders, which can limit how much potential upside remains if expectations...
NasdaqGS:ZION
NasdaqGS:ZIONBanks

Zions Bancorporation (ZION) Lifts Dividend 6.7% And Adds $75 Million Buyback

Zions Bancorporation National Association (NasdaqGS:ZION) announced a 6.7% increase in its quarterly common dividend. The company also authorized a new US$75 million share repurchase program scheduled for the third quarter of 2026. Zions Bancorporation National Association focuses on regional banking services, including lending, deposit gathering, and treasury offerings for businesses and consumers. Dividend decisions and buyback authorizations are closely watched in the banking sector,...
NYSE:RCUS
NYSE:RCUSBiotechs

How Investors May Respond To Arcus Biosciences (RCUS) Expanding ARC-20 With New Kidney Cancer Combo

Arcus Biosciences and Summit Therapeutics previously announced a clinical trial collaboration to test Arcus’s oral HIF-2a inhibitor casdatifan with Summit’s PD-1/VEGF bispecific antibody ivonescimab in metastatic clear cell renal cell carcinoma, adding a new combination cohort to Arcus’s ongoing ARC-20 platform study. An interesting aspect of this collaboration is that both companies retain full rights to their own drugs while sharing study costs, potentially expanding each firm’s kidney...
NYSE:CRCL
NYSE:CRCLSoftware

Circle Internet Group (CRCL) Faces A New Valuation Test Following New York Trust Approval

Circle Internet Group (CRCL) has secured a limited purpose trust charter from the New York Department of Financial Services for Circle New York Trust, a development that sharpens the regulatory profile around USDC oversight and custody operations. See our latest analysis for Circle Internet Group. Despite the New York trust charter and earlier approval to establish a national trust bank, Circle Internet Group’s 1-year total shareholder return declined 62.75%, with the share price at $62.61...
NYSE:GS
NYSE:GSCapital Markets

Goldman Sachs Group (GS) Faces A 4% Premium On Funding Activity

Goldman Sachs Group (GS) has been very active in its funding mix, with a fresh wave of fixed income offerings across multiple maturities and coupon levels providing investors with more detail on how the firm is raising capital. See our latest analysis for Goldman Sachs Group. Goldman Sachs Group shares recently eased, with a 7 day share price return of 4.04% and a 1 day move of 0.63% lower. However, the 90 day share price return of 10.25% and 1 year total shareholder return of 46.41% indicate...
NYSE:GWW
NYSE:GWWTrade Distributors

Is W.W. Grainger (GWW) Expensive On Earnings Growth Hopes Ahead Of Results?

Recent commentary around W.W. Grainger (GWW) has focused on expectations for year over year growth in sales and earnings per share ahead of its upcoming quarterly report, giving investors fresh context for the stock. See our latest analysis for W.W. Grainger. Against this backdrop, W.W. Grainger’s share price has climbed 20.34% over the past 90 days and 37.70% year to date, while its 1 year total shareholder return of 49.53% reflects recent performance. If Grainger’s move has you thinking...
NYSE:GPGI
NYSE:GPGITech

GPGI (GPGI) Is Down 5.8% After Husky Deal Misrepresentation Lawsuits Emerge What's Changed

Since late July 2026, several law firms, including Kaplan Fox, Pomerantz, and Rosen Law Firm, have launched securities class action lawsuits against GPGI, Inc. over alleged misleading statements tied to its Husky Technologies Limited acquisition and subsequent earnings and guidance updates. These legal actions focus on whether investors were misinformed about the valuation and expected benefits of the Husky deal, raising fresh questions about GPGI’s disclosure practices and...
NasdaqGS:NVDA
NasdaqGS:NVDASemiconductor

How NVIDIA’s AI Factories And Full‑Stack Partnerships At NVIDIA (NVDA) Have Changed Its Investment Story

Over the past week, a flurry of announcements has seen partners like SK Group, NAVER, Amkor, F5, Silvaco, Synopsys and Siemens deepen their use of NVIDIA platforms, while NVIDIA committed billions to AI factories, next‑generation chips and long-term collaborations across semiconductors, data centers and advanced agentic AI. Together with CEO Jensen Huang’s push into financing large AI campuses and reinforcing memory supply, these moves show NVIDIA extending far beyond chip sales into owning...
NasdaqGS:ALGT
NasdaqGS:ALGTAirlines

Allegiant Travel (ALGT) Adds Premium Seating, Is It Still A Bargain?

Allegiant Travel (ALGT) has drawn fresh attention after announcing complimentary inflight beverage service and a new premium seating tier, Allegiant First, aimed at broadening its appeal to leisure travelers across its network. See our latest analysis for Allegiant Travel. The new onboard offerings come after a sharp share price swing for Allegiant Travel, with the stock down 17.69% on a 1 month share price return but up 30.74% over 3 months and a 1 year total shareholder return of 103.82%,...
NasdaqGS:HST
NasdaqGS:HSTHotel and Resort REITs

Host Hotels & Resorts (HST) Stock Looks Below Fair Value While Returns Already Look Strong

Host Hotels & Resorts has delivered a 97.7% total return over the past five years, yet valuation checks suggest the stock may still trade below an estimate of its intrinsic value. The key question is how much weight to give a Discounted Cash Flow (DCF) estimate that points to upside versus a broader set of checks that only signal a mixed value picture. A 97.7% return over five years puts Host Hotels & Resorts firmly in the group of stocks that have already rewarded patient shareholders,...
NYSE:JBGS
NYSE:JBGSOffice REITs

Has JBG SMITH Properties (JBGS) Fallen Far Enough to Look Cheap?

JBG SMITH Properties has seen its share price fall 43.7% over the past five years, yet current valuation work suggests the stock may now be trading below its estimated intrinsic value based on a Discounted Cash Flow (DCF) model and traditional market multiples. The share price decline of 43.7% over five years raises the question of whether sentiment has become more pessimistic than the underlying fundamentals justify. Future cash generation from JBG SMITH Properties' property portfolio can...
NYSE:KMPR
NYSE:KMPRInsurance

Is Kemper (KMPR) Undervalued Following Its Auto Leadership Change?

Kemper (KMPR) drew investor attention after announcing that Matthew A. Hunton will leave his role as Executive Vice President and President of Kemper Auto on August 3, 2026, raising fresh questions about its auto segment. See our latest analysis for Kemper. At a share price of US$28.38, Kemper has seen pressure build over time, with the stock falling over the year to date and a 1-year total shareholder return that is also sharply lower, suggesting sentiment around both its auto operations and...
NYSE:NVT
NYSE:NVTElectrical

The Bull Case For nVent Electric (NVT) Could Change Following Record Q2 Results And Cooling Expansion

nVent Electric plc recently reported past second-quarter 2026 results with sales of US$1,471.3 million and net income of US$215.9 million, alongside leasing a new 160,000 square-foot Blaine, Minnesota facility to expand data center liquid cooling production. The combination of record quarterly performance and a third liquid cooling capacity expansion in three years underscores how AI-driven data center demand is reshaping nVent’s business mix and growth priorities. We’ll now examine how the...
NYSE:PNFP
NYSE:PNFPBanks

3 Bank Stocks To Watch As Higher Treasury Yields Reshape Lending Margins

The bond market just sent a loud message. The Federal Reserve under Kevin Warsh kept rates on hold, yet long term Treasury yields surged to levels last seen in 2007 while shorter yields eased. At the same time, the Fed’s limited guidance has left investors guessing about inflation and future volatility. For banks and insurers with solid balance sheets, that mix of higher long term rates and shaken Fed credibility can create both openings and traps. This article walks through three financially...
NasdaqCM:BFC
NasdaqCM:BFCBanks

Bank First (BFC) Stock May Be 11% Overvalued Following Strong Q2 Earnings

Bank First stock has delivered a 137.8% return over the past 5 years, yet current valuation checks and the latest intrinsic value estimate suggest the shares may now be trading at a premium rather than offering clear value. A 137.8% share price gain over 5 years points to a stock that has already rewarded long term holders, which raises the bar for future returns from today’s price. Recent earnings growth and a higher dividend can support investors’ expectations, while any disappointment in...
NYSE:BLK
NYSE:BLKCapital Markets

BlackRock (BLK) Partners With Meta On $14 Billion AI Data Center Deal

BlackRock agreed a $14b partnership with Meta Platforms to fund and operate a new AI data center campus in El Paso, Texas through an 80/20 equity split using an off balance sheet, sale leaseback style structure. The company is extending its BUIDL tokenized Treasuries platform through a new integration with Tempo that targets institutional finance and blockchain based settlement. BlackRock is also adding exposure to media and entertainment assets via Anthem Entertainment catalogs acquired...
NYSE:FLG
NYSE:FLGBanks

The Bull Case For Flagstar Bank (FLG) Could Change Following New Guidance And $250 Million Buyback

Flagstar Bank, National Association recently reported second-quarter 2026 results showing net income of US$34 million versus a loss a year earlier, issued 2026–2027 earnings guidance, declared quarterly dividends on its common and preferred stock, and authorized up to US$250 million of share repurchases over the next 12 months. Alongside modest net charge-offs of US$100,000, management framed the quarter as an inflection point, highlighting a deliberate shift away from commercial real estate...
NYSE:PFE
NYSE:PFEPharmaceuticals

Butterfly Network Stock And Other AI Healthcare Names With Real Clinical Use

AI in healthcare sits at the crossroads of powerful trends that matter for investors, from aging populations and rising treatment costs to central banks wrestling with inflation and bond yields. While higher yields and shifting policy expectations keep pressure on parts of the market, the Transformative AI Healthcare Stocks screener focuses on companies using AI to improve diagnostics, treatment decisions, hospital efficiency and remote care. These tools aim to cut waste, support clinicians...